CoChat

Evaluation of AlphaFold structure-based protein stability prediction on missense variations in cancer

Open access
Keskin Karakoyun, Hilal, Yüksel, Şirin K., Amanoglu, Ilayda, Naserikhojasteh, Lara, Yeşilyurt, Ahmet, Yakıcıer, Cengiz, Timuçin, Emel, Akyerli, Cemaliye B. · 2023 · Frontiers in Genetics
Cited by 58

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Identifying pathogenic missense variants in hereditary cancer is critical to the efforts of patient surveillance and risk-reduction strategies. For this purpose, many different gene panels consisting of different number and/or set of genes are available and we are particularly interested in a panel of 26 genes with a varying degree of hereditary cancer risk consisting of ABRAXAS1, ATM, BARD1, BLM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM, MEN1, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, PTEN, RAD50, RAD51C, RAD51D, STK11, TP53, and XRCC2. In this study, we have compiled a collection of the missense variations reported in any of these 26 genes. More than a thousand missense variants were collected from ClinVar and the targeted screen of a breast cancer cohort of 355 patients which contributed to this set with 160 novel missense variations. We analyzed the impact of the missense variations on protein stability by five different predictors including both sequence- (SAAF2EC and MUpro) and structure-based (Maestro, mCSM, CUPSAT) predictors. For the structure-based tools, we have utilized the AlphaFold (AF2) protein structures which comprise the first structural analysis of this hereditary cancer proteins. Our results agreed with the recent benchmarks that computed the power of stability predictors in discriminating the pathogenic variants. Overall, we reported a low-to-medium-level performance for the stability predictors in discriminating pathogenic variants, except MUpro which had an AUROC of 0.534 (95% CI [0.499–0.570]). The AUROC values ranged between 0.614–0.719 for the total set and 0.596–0.682 for the set with high AF2 confidence regions. Furthermore, our findings revealed that the confidence score for a given variant in the AF2 structure could alone predict pathogenicity more robustly than any of the tested stability predictors with an AUROC of 0.852. Altogether, this study represents the first structural analysis of the 26 hereditary cancer genes underscoring 1) the thermodynamic stability predicted from AF2 structures as a moderate and 2) the confidence score of AF2 as a strong descriptor for variant pathogenicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fgene.2023.1052383

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 39

  1. Akbari, 2009, Germline RAP80 mutations and susceptibility to breast cancer, Breast Cancer Res. Treat., 113, 377, 10.1007/s10549-008-9938-z · DOI
  2. Andreotti, 2010, Prediction of the responsiveness to pharmacological chaperones: Lysosomal human alpha-galactosidase, a case of study, Orphanet J. rare Dis., 5, 36, 10.1186/1750-1172-5-36 · DOI
  3. Angeli, 2020, Genetic predisposition to breast and ovarian cancers: How many and which genes to test?, Int. J. Mol. Sci., 21, 1128, 10.3390/ijms21031128 · DOI
  4. Baretic, 2017, Structures of closed and open conformations of dimeric human ATM, Sci. Adv., 3, e1700933, 10.1126/sciadv.1700933 · DOI · Paper page
  5. Birolo, 2021, Protein stability perturbation contributes to the loss of function in haploinsufficient genes, Front. Mol. Biosci., 8, 620793, 10.3389/fmolb.2021.620793 · DOI
  6. Brouckaert, 2012, Update on triple-negative breast cancer: Prognosis and management strategies, Int. J. Womens Health, 4, 511, 10.2147/IJWH.S18541 · DOI
  7. Buisson, 2010, Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination, Nat. Struct. Mol. Biol., 17, 1247, 10.1038/nsmb.1915 · DOI · Paper page
  8. Burley, 2021, Open-access data: A cornerstone for artificial intelligence approaches to protein structure prediction, Structure, 29, 515, 10.1016/j.str.2021.04.010 · DOI · Paper page
  9. Catana, 2019, Multi gene panel testing for hereditary breast cancer - is it ready to be used?, Med. Pharm. Rep., 92, 220, 10.15386/mpr-1083 · DOI
  10. Chen, 2020, Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer, Aging, 12, 3140, 10.18632/aging.102783 · DOI
  11. Cheng, 2006, Prediction of protein stability changes for single-site mutations using support vector machines, Proteins, 62, 1125, 10.1002/prot.20810 · DOI · Paper page
  12. Colas, 2019, Decoding hereditary breast cancer" benefits and questions from multigene panel testing, Breast, 45, 29, 10.1016/j.breast.2019.01.002 · DOI
  13. DeBoever, 2018, Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study, Nat. Commun., 9, 1612, 10.1038/s41467-018-03910-9 · DOI · Paper page
  14. Fanale, 2020, Detection of germline mutations in a cohort of 139 patients with bilateral breast cancer by multi-gene panel testing: Impact of pathogenic variants in other genes beyond BRCA1/2, Cancers, 12, 2415, 10.3390/cancers12092415 · DOI
  15. Gaboriau, 2015, Protein stability versus function: Effects of destabilizing missense mutations on BRCA1 DNA repair activity, Biochem. J., 466, 613, 10.1042/BJ20141077 · DOI
  16. Gerasimavicius, 2020, Identification of pathogenic missense mutations using protein stability predictors, Sci. Rep., 10, 15387, 10.1038/s41598-020-72404-w · DOI · Paper page
  17. Gradishar, 2022, Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology, J. Natl. Compr. Cancer Netw. JNCCN, 20, 691, 10.6004/jnccn.2022.0030 · DOI · Paper page
  18. Hu, 2020, The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort, J. Natl. Cancer Inst., 112, 1231, 10.1093/jnci/djaa023 · DOI
  19. Jeni, 2013, Facing imbalanced data recommendations for the use of performance metrics. International conference on affective computing and intelligent interaction and workshops: [proceedings], ACII, 245
  20. Kebabci, 2022, Toward compilation of balanced protein stability data sets: Flattening the ΔΔG curve through systematic enrichment, J. Chem. Inf. Model, 62, 1345, 10.1021/acs.jcim.2c00054 · DOI
  21. Laimer, 2015, MAESTRO--multi agent stability prediction upon point mutations, BMC Bioinforma., 16, 116, 10.1186/s12859-015-0548-6 · DOI · Paper page
  22. Li, 2021, SAAMBE-SEQ: A sequence-based method for predicting mutation effect on protein-protein binding affinity, Bioinformatics, 37, 992, 10.1093/bioinformatics/btaa761 · DOI
  23. Marmorstein, 1998, The BRCA2 gene product functionally interacts with p53 and RAD51, Proc. Natl. Acad. Sci. U. S. A., 95, 13869, 10.1073/pnas.95.23.13869 · DOI · Paper page
  24. Ng, 2003, Sift: Predicting amino acid changes that affect protein function, Nucleic acids Res., 31, 3812, 10.1093/nar/gkg509 · DOI · Paper page
  25. Nishi, 2013, Cancer missense mutations alter binding properties of proteins and their interaction networks, PLoS One, 8, e66273, 10.1371/journal.pone.0066273 · DOI · Paper page
  26. Parthiban, 2006, Cupsat: Prediction of protein stability upon point mutations, Nucleic acids Res., 34, W239, 10.1093/nar/gkl190 · DOI · Paper page
  27. Peleg Hasson, 2020, Comparison of patient susceptibility genes across breast cancer: Implications for prognosis and therapeutic outcomes, Pharmacogenomics personalized Med., 13, 227, 10.2147/PGPM.S233485 · DOI
  28. Pettersen, 2004, UCSF Chimera--a visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084 · DOI · Paper page
  29. Pires, 2014, mCSM: predicting the effects of mutations in proteins using graph-based signatures, Bioinformatics, 30, 335, 10.1093/bioinformatics/btt691 · DOI · Paper page
  30. Rainville, 2014, Next-generation sequencing for inherited breast cancer risk: Counseling through the complexity, Curr. Oncol. Rep., 16, 371, 10.1007/s11912-013-0371-z · DOI
  31. Reid, 2020, Update on multi-gene panel testing and communication of genetic test results, Breast J., 26, 1513, 10.1111/tbj.13971 · DOI
  32. Sanavia, 2020, Limitations and challenges in protein stability prediction upon genome variations: Towards future applications in precision medicine, Comput. Struct. Biotechnol. J., 18, 1968, 10.1016/j.csbj.2020.07.011 · DOI · Paper page
  33. Stakyte, 2021, Molecular basis of human ATM kinase inhibition, Nat. Struct. Mol. Biol., 28, 789, 10.1038/s41594-021-00654-x · DOI
  34. Stefl, 2013, Molecular mechanisms of disease-causing missense mutations, J. Mol. Biol., 425, 3919, 10.1016/j.jmb.2013.07.014 · DOI · Paper page
  35. Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA a cancer J. Clin., 71, 209, 10.3322/caac.21660 · DOI · Paper page
  36. Tokuriki, 2008, How protein stability and new functions trade off, PLoS Comput. Biol., 4, e1000002, 10.1371/journal.pcbi.1000002 · DOI · Paper page
  37. Warren, 2022, Structure of the human ATM kinase and mechanism of Nbs1 binding, eLife, 11, e74218, 10.7554/eLife.74218 · DOI
  38. Witham, 2011, A missense mutation in CLIC2 associated with intellectual disability is predicted by in silico modeling to affect protein stability and dynamics, Proteins, 79, 2444, 10.1002/prot.23065 · DOI · Paper page
  39. Woodard, 2021, Protein structural features predict responsiveness to pharmacological chaperone treatment for three lysosomal storage disorders, PLoS Comput. Biol., 17, e1009370, 10.1371/journal.pcbi.1009370 · DOI

Cited by

See all 58

Metadata

Authors
Keskin Karakoyun, H., Yüksel, Ş. K., Amanoglu, I., Naserikhojasteh, L., Yeşilyurt, A., Yakıcıer, C., Timuçin, E., & Akyerli, C. B.
Venue
Frontiers in Genetics
Published
2023-02-21
Volume
14
Pages
1052383-1052383
ISSN
1664-8021 (ISSN-L)
OpenAlex
W4321459326
Cited by
58
References
25
FWCI
8.50
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of AlphaFold structure-based protein stability prediction on missense variations in cancer. https://app.cochat.ai/papers/10.3389/fgene.2023.1052383
The paper
Keskin Karakoyun, H., Yüksel, Ş. K., Amanoglu, I., Naserikhojasteh, L., Yeşilyurt, A., Yakıcıer, C., Timuçin, E., & Akyerli, C. B. (2023). Evaluation of AlphaFold structure-based protein stability prediction on missense variations in cancer. Frontiers in Genetics. https://doi.org/10.3389/fgene.2023.1052383

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.